SciELO - Scientific Electronic Library Online

 
vol.81 número5Restricción cognitiva durante la cuarentena por COVID-19Artrodesis lumbosacra en trabajadores de la construcción. Reinserción laboral índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Medicina (Buenos Aires)

versión impresa ISSN 0025-7680versión On-line ISSN 1669-9106

Medicina (B. Aires) vol.81 no.5 Ciudad Autónoma de Buenos Aires oct. 2021

 

ORIGINAL ARTICLE

Analysis of visual disability in Buenos Aires, Argentina. Pathologic myopia is the leading cause in working age

Análisis de discapacidad visual en Buenos Aires, Argentina. La miopía patológica es la principal causa en edad laboral

Pablo J. Franco1 

Alejandro Suwezda2 

Patricio Schlottmann3 

María Pía Destefanis1 

Ruth E. Rosenstein4 

Rafael Iribarren5  * 

Andrzej Grzybowski6  7 

1 Hospital Santa Lucía, Buenos Aires, Argentina

2 Fundación Hospitalaria, Buenos Aires, Argentina

3 Organización Médica de Investigación (OMI), Buenos Aires, Argentina

4 Laboratorio de Neuroquímica Retinal y Oftalmología Experimental, Departamento de Bioquímica Humana, Facultad de Medicina/CEFyBO, Universidad de Buenos Aires/CONICET, Buenos Aires, Argentina

5 Consultorio Dres. Iribarren, Buenos Aires, Argentina

6 Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland

7 Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland

Abstract

This study assessed the causes of visual impairment over a decade in Buenos Aires City. This is a retrospective case series where we reviewed the database of visual disability certificates issued by the Buenos Aires City Ministry of Health between 2009 and 2017. In Argentina, visual disability is defined as a visual acuity ≤ 20/200 in the better eye, or a corresponding visual field of less than 20 degrees in the less impaired eye. The database included the following variables: year of issue, age, gender, and cause of visual disability. Between 2009 and 2017 a total of 7656 subjects were certified as legally blind. The mean age of the sample was 57 ± 21 years and 52.1% were females. The emission was near 700 certificates per year. The age distribution showed that 62.8% of certificates were from patients older than 50 years and that only 6.6% were given to subjects under 20. The leading causes of visual disability in Buenos Aires City were age-related macular degeneration (ARMD) with a rate of 15.5%, degenerative myopia (14.4%), primary open-angle glaucoma (11.3%) and diabetic retinopathy (6.6%). In subjects younger than 50, degenerative myopia was the first cause of visual disability. Interestingly in Argentina, where the prevalence of myopia is low, degenerative myopia is found to be the major cause of visual disability in middle-aged adult subjects. Population and clinical methods to avoid this preventable disease should need to be implemented as a matter of urgency.

Key words: Visual disability; Degenerative myopia; Glaucoma; Macular degeneration

Resumen

Este trabajo estudia las causas de la discapacidad visual durante una década en la Ciudad de Buenos Aires. Se presenta una serie de casos retrospectiva donde se revisó la base de datos de certificados de discapacidad visual emitidos por el Ministerio de Salud de la Ciudad de Buenos Aires entre 2009 y 2017. En Argentina, la discapacidad visual se define como una agudeza visual ≤ 20/200 en el mejor ojo, o un campo visual correspondiente de menos de 20 grados en el ojo menos deteriorado. La base de datos incluyó las siguientes variables: año de emisión, edad, sexo y causa de la discapacidad visual. Entre 2009 y 2017 se certificaron un total de 7656 sujetos con ceguera legal. La edad media de la muestra fue de 57 ± 21 años y el 52.1% fueron mujeres. La distribución por edades mostró que el 62.8% de los certificados fueron dados a pacientes mayores de 50 años y que solo el 6.6% se otorgó a menores de 20 años. Las principales causas de discapacidad visual fueron la degeneración macular asociada a la edad (DMAE) (15.5%), la miopía degenerativa (14.4%), el glaucoma primario de ángulo abierto (11.3%) y la retinopatía diabética (6.6%). En los menores de 50 años, la miopía degenerativa fue la primera causa de discapacidad visual. Resulta interesante que, en Argentina, donde la prevalencia de miopía es baja, la miopía degenerativa sea la principal causa de discapacidad visual en adultos de mediana edad.

Palabras clave: Discapacidad visual; Miopía degenerativa; Glaucoma; Degeneración macular

KEY POINTS

Current knowledge

• The prevalence of strong myopia in Argentina is very low in adults, but there are no studies of visual impairment due to this condition.

Article contribution to current knowledge

• The study of the issuance of Certificates of Visual Dis ability of the City of Buenos Aires showed that strong myopia is the main cause of visual disability in working age.

Public health policies, such as planning of specific prevention programs, defining the national budget and developing health services, need epidemiological data on the causes of visual impairment and blindness1-5. Cataract, macular degeneration, glaucoma, diabetic retinopathy, trachoma, and uncorrected refractive errors have been identified as the most prevalent causes of legal blindness and vision impairment worldwide1,6-9. Most studies have focused on one population within a circumscribed region, but differences among ethnic groups, environmental fac tors, demographic parameters and lifestyle can affect the prevalence and causes of vision loss.

Argentina has been a country of immigration since the time of the colony. Buenos Aires city is an extended devel oped urban environment of ∼ 3 million people with different ethnic origins and varied family incomes or lifestyles. Most inhabitants are of Italian, Spanish, and German descent as European immigration after year 1880 doubled the original colonial population in few decades. In addition, there are many collectivities, as French, British, Jewish, Ukrainians, Arabs, Japanese or Chinese, among others, and a minority of old Creoles who date back to the Spanish colonial days. The Creole and Spanish-Aboriginal (mixed) population in the city has recently increased as a result of immigration from inner provinces and South American Spanish speaking bordering countries such as Bolivia, Paraguay, Chile, and Peru during the second half of the 20th century. In this context, the demographic complexity of Buenos Aires City inhabitants makes it an interesting scenario to analyze the causes of visual impairment in a mixed affluent population of Latin America. Such analysis could serve as basis for the region, where this type of study has not been yet performed to our knowledge.

Besides, epidemiological data about the prevalence and causes of low vision and blindness in Argentina in general, and in Buenos Aires City in particular, are scarce. The prevalence of blindness in Buenos Aires Province has been reported as 1.1% in people older than 50 years of age, with treatable cataract being the main cause of this vision impairment7. Moreover, a high prevalence of blind ness resulting from cataract was shown in the north-west district of Buenos Aires Province10 and in a representative cross-sectional population study in Argentina11. Cataract is a preventable cause of vision impairment, but data on the prevalence of age-related macular degeneration (ARMD), glaucoma, diabetic retinopathy, and other major causes of visual disability in Argentina are not yet available.

There is only one institution in Buenos Aires City au thorized to grant a personal visual impairment certificate (Santa Lucía Ophthalmologic Municipal Hospital). Since these certificates offer several benefits, such as a monthly pension, transport or tax discount, and 100% coverage for all medications and treatment costs, most individuals with visual disabilities in the City of Buenos Aires apply. The law 24.901 for this certificate was promulgated in 1997 but it was not until the years 2000 that people began to be aware of its importance and associated benefits. The aim of this study was to identify the main causes of legal blindness in Buenos Aires City. These data were obtained from the database of ocular disability certificates issued by the Santa Lucía Hospital between 2009 and 2018.

Materials and methods

In Argentina, visual disability is defined as a visual acuity ≤ 20/200 or a corresponding visual field of less than 20 de grees in the less impaired eye. A certificate of visual disability is issued by the Ministry of Health of Buenos Aires City for all individuals who meet the above definition. The procedure consists of a complete eye examination by an ophthalmologist, including best corrected visual acuity testing, visual field test ing and a complete ophthalmologic examination with Goldman tonometry, anterior segment biomicroscopy under slit-lamp and fundus evaluation after pupil dilation. The ophthalmologists sent eligible patients to the certification process which was carried out at Santa Lucía Hospital. Patients were re-examined by an Evaluation Committee. If the diagnosis was confirmed, each patient received the certificate using the 10th revision of the International Classification of Disease (ICD-10) to codify the cause of visual disability.

All the information of the emitted visual disability certificates gathered between years 2009 to 2017 was comprehensively collected in a dataset. The database included the following variables: name, ID number, year of issue of the certificate, age, gender and major cause of visual disability (ICD-10 classification system). An independent investigator built an excel database replacing each patient´s name, surname and ID number by correlative numbers to provide the research team with a new excel database, so that none of the patients could be identified during the analysis, according to the ethi cal recommendations. All data were maintained confidential in accordance to the Declaration of Helsinki. The present study was approved by the Institutional’s Review Board of the Santa Lucía Hospital and by the Santa Lucía Hospital Ethics Com mitte (Register Code 2645).

The relative prevalence of each cause of visual disability was studied by age and gender, and presented as relative percentage of the studied sample. Chi Square tests were used for finding differences in these prevalences for each individual disease. The R Project for Statistical Computing Sofware (ver sion 3.2.0) and SPSS version 15 (SPSS, USA) were used to perform the statistical analysis. Age, time (in years), gender and the interaction between each independent variable were included in the analysis. Differences were considered statisti cally significant with p < 0.05.

Results

In nine years-time (2009 to 2017) a total of 7656 subjects were certified as legally blind by the Hospital Santa Lucía in the city of Buenos Aires. The mean age of the sample was 57 ± 21 years (range from newborns to 101 years) and 52.1% were females. The emission was near 700 certificates per year. The age distribution of the sample showed that 62.8% of certificates were from patients older than 50 years and that only 6.6% were given to subjects under 20.

In all, visual disability was classified in 286 different diagnoses according to the ICD10 classification system. The distribution of the 50 principal causes of visual dis ability certificates issued during the study period is shown in Table 1, with 7022 subjects (91.7% of the sample). The leading causes of visual disability in Buenos Aires City were age-related macular degeneration (ARMD) with a rate of 15.5% (n = 1186), degenerative myopia (14.4%, n = 1104), primary open-angle glaucoma (11.3%, n = 865) and diabetic retinopathy (6.6%, n = 504). Phthisis bulbi, although reached 6.8% (n = 522) prevalence of certifi cates, is not a true disease but the final stage of many different diseases, so it was not included among the principal diseases.

Table 1 Fifty most frequent diagnosis of visual disability 

The analysis of the five main diseases of visual disabil ity along age of the sample is shown in Figure 1 (ARMD, primary open angle glaucoma, degenerative myopia, diabetic retinopathy and hereditary retinal dystrophies). It can be seen that degenerative myopia, diabetic reti nopathy and hereditary retinal dystrophies are producing disability in the middle working ages, while glaucoma and ARMD produce disability later in life. There was no clear tendency of these diseases to change their relative preva lence along the time of the study except for an increase in recent years of the relative prevalence of ARMD (Pearson 0.833, p = 0.005) (Table 2).

Fig. 1 Distribution of number of subjects for each of the principal diseases along ages. In this cross-sectional data it can be seen that degenerative myopia and diabetes peak at ages 50-60, age-related macular degeneration (ARMD) and glaucoma peak at older ages, and hereditary retinal dystrophies are distributed evenly across all ages 

Table 2 Relative percentages of the five principal diagnosis according to year of issue (n = 4068 subjects) 

Degenerative myopia was the leading cause of dis ability in subjects younger than 50, while ARMD was the leading cause in those older than 50 (Fig. 2).

Fig. 2 The distribution of disease in younger and older subjects. It can be clearly seen that degenerative myopia is by much the leading cause of disability in younger subjects, while ARMD is the leading cause in those older than 50 

Discussion

Worldwide studies about vision impairment began by the end of the 90s1 and after their data were available, many countries began to implement laws for emitting visual disability certificates, social security benefits and reha bilitation programs for the affected people. Uncorrected refractive errors and cataract are the leading causes of vision impairment worldwide and are generally not considered for emitting permanent disability certificates because these diseases can be treated. The present study is interesting in the sense that shows the causes of visual disability certificate emissions, and few previous studies of this kind could be found. One was performed in Israel12,13, other in England and Wales14, a third in Ireland15 and a fourth in China16. The records of the Israeli study from 1998 to 2008 showed that for a country population of 7 million, 19 862 newly certificates of vision disability were emit ted in 10 years (2.8‰) while in Buenos Aires there were 7656 in 3 million inhabitants (2.5‰). The five principal causes of disability in the Israeli study, in 2008, were AMD (28.7%), diabetic retinopathy (13.2%), glaucoma (12.1%), cataract (5.1%) and retinitis pigmentosa (7.8%), leaving 46.0% for other causes in which probably degenerative myopia was included12,13,17. The England and Wales study (1999) involved 13 723 blind subjects with certificates and here again degenerative myopia was not reported14 but when the study was repeated in 2010 then degenerative myopia was informed at a rate of 2.8% in working age population (16-64 years)18. Interestingly, the Irish study also reported on visual disability in the working population (16-64 years) showing that hereditary dystrophies (reti nitis pigmentosa + albinism) had a relative prevalence in certificates of 23.4%, myopia 6.6%, glaucoma 6.0% and diabetes 3.5% (this was in 1998, before the epidemics of myopia in East and South East Asia). A very recent visual disability certificates study in Shanghai (Jing-An District)16 showed that the relative prevalence of vision impairment due to myopic maculopathy increased from 14.5% in 2001 to 26.1% in 2007, when it became the leading cause of vision disability. A study in 1989 performed in Australian Royal Blind Society showed ARMD and glaucoma were the leading causes of certificate emission, but here again myopia was reported among other diagnosis19.

In general terms, the most prevalent causes of visual impairment identified in this study were ARMD and de generative myopia (both near 15%). The high prevalence of degenerative myopia is interesting in the context that Buenos Aires City, as previously described by Cortinez et al.,20 has 2.3% prevalence of high myopia (greater than -5.00 diopters, prone to myopic maculopathy) in an unselected sample of highly educated office workers. Pathologic myopia is an important cause of vision loss worldwide, affecting up to 3% of the population21. Studies performed in China and Japan found that pathologic myo pia was the cause of blindness or low vision in 12.2-27.4% of individuals with visual impairment22-24, while The Los Angeles Latino Eye Study reported that pathologic myopia was the cause of blindness or low vision in 4.5% of Latin American residents in Los Angeles25. A survey performed in Australia, clearly showed the exponential increase of vision loss with increasing age and supports the impact that increased ageing of the population will have on the number of people with vision loss and blindness9. Interestingly, degenerative myopia was there the second leading cause of disability at all ages, and by much the leading cause of disability in people younger than 50. High myo pia usually has early onset between 6-10 years of age in early school years, and when detected can undergo treatment to prevent progression up to high myopia in the next five years (if the children progress at a rate of -1.00 diopters per year, as is usually seen). The most effective treatment today is the instillation of diluted atropine drops in a regular annual basis26-29. It is important that pediatric and general ophthalmologists refracting schoolchildren be aware that the disease progression can be limited, as high myopia and its macular complications have been now shown to be major causes of vision impairment at early adult ages.

The principal study limitation is the cross-sectional design but as certificates are emitted for a period of 10 years-time, we can be sure that no subject was dupli cated. Other concern could be the lack of evidence that this sample is population based, representing the vision impairment prevalence in Buenos Aires. In this sense, as medical coverage for rehabilitation of vision impairment covers treatment costs and low vision visual aids only for those with visual disability certificates, and ophthalmolo gists in Argentina are encouraged to send patients to vi sion rehabilitation, we then argue that most vision impaired subjects are possibly included in this centralized database.

Interestingly, degenerative myopia was the second leading cause of disability at all ages, and by much the leading cause of disability in people younger than 50. Thus, in Buenos Aires, where the prevalence of high myopia has been shown to be low, degenerative myopia was found to be the major cause of visual disability in younger subjects. The reason for that is not clear and should be further studied. Moreover, recently introduced methods to control the progression of myopia and high myopia28, should be actively propagated in Argentina to prevent this vision disability. The treatment of early onset cases of myopia in primary school years, the ones that are prone to develop myopic maculopathy, could arrest their progression and avoid that disability. As prevention programs would show results after long time when these children have grown up to adulthood, urgent preventive programs are needed.

Acknowledgements:

Authors wish to thank Prof. Dr. Jos Rozema (Belgium) for his help with figures and analysis.

References

1. Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health 2013; 1: e339-49. [ Links ]

2. Bourne RRA, Jonas JB, Bron AM, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol 2018; 102: 575-85. [ Links ]

3. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990- 2020: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e1221-e34. [ Links ]

4. Nangia V, Jonas JB, George R, et al. Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia. Br J Ophthalmol 2019; 103: 871-7. [ Links ]

5. Leasher JL, Braithwaite T, Furtado JM, et al. Prevalence and causes of vision loss in Latin America and the Ca ribbean in 2015: magnitude, temporal trends and projec tions. Br J Ophthalmol 2019; 103: 885-93. [ Links ]

6. Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477-85. [ Links ]

7. Furtado JM, Lansingh VC, Carter MJ, et al. Causes of blindness and visual impairment in Latin America. Surv Ophthalmol 2012; 57: 149-77. [ Links ]

8. Schellini SA, Durkin SR, Hoyama E, et al. Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study. BMC Ophthalmol 2009; 9: 8. [ Links ]

9. Taylor HR, Keeffe JE, Vu HT, et al. Vision loss in Australia. Med J Aust 2005; 182: 565-8. [ Links ]

10. Nano ME, Nano HD, Mugica JM, et al. Rapid assessment of visual impairment due to cataract and cataract surgical services in urban Argentina. Ophthalmic Epidemiol 2006; 13: 191-7. [ Links ]

11. Barrenechea R, de la Fuente I, Plaza RG, et al. Encuesta nacional de ceguera y deficiencia visual evitable en Argentina, 2013. Rev Panam Salud Publica 2015; 37: 7-12. [ Links ]

12. Belkin M, Kalter-Leibovici O, Chetrit A, Skaat A. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol 2013; 155: 404. [ Links ]

13. Skaat A, Chetrit A, Belkin M, et al. Time trends in the incidence and causes of blindness in Israel. Am J Oph thalmol 2012; 153: 214-21 e1. [ Links ]

14. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58. [ Links ]

15. Munier A, Gunning T, Kenny D, O’Keefe M. Causes of blindness in the adult population of the Republic of Ire land. Br J Ophthalmol 1998; 82: 630-3. [ Links ]

16. Wu L, Sun X, Zhou X, Weng C. Causes and 3-year-inci dence of blindness in Jing-An District, Shanghai, China 2001-2009. BMC Ophthalmol 2011; 11: 10. [ Links ]

17. Avisar R, Friling R, Snir M, et al. Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J 2006; 8: 880-1. [ Links ]

18. Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open 2014; 4: e004015. [ Links ]

19. Chan CW, Billson FA. Visual disability and major causes of blindness in NSW: a study of people aged 50 and over attending the Royal Blind Society 1984 to 1989. Aust N Z J Ophthalmol 1991; 19: 321-5. [ Links ]

20. Cortinez MF, Chiappe JP, Iribarren R. Prevalence of refrac tive errors in a population of office-workers in Buenos Aires, Argentina. Ophthalmic Epidemiol 2008; 15: 10-6. [ Links ]

21. Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic cho roidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 2014; 157: 9-25 e12. [ Links ]

22. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology 2006; 113: 1134 e1-11. [ Links ]

23. Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 2006; 113: 1354-62. [ Links ]

24. Yamada M, Hiratsuka Y, Roberts CB, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 2010; 17: 50-7. [ Links ]

25. Cotter SA, Varma R, Ying-Lai M, et al. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2006;113(9): 1574-82. [ Links ]

26. Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res 2018; 62: 134-49. [ Links ]

27. Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI - Clinical Myopia Control Trials and Instrumentation Report. Invest Ophthalmol Vis Sci 2019; 60: M132-M60. [ Links ]

28. Wildsoet CF, Chia A, Cho P, et al. IMI - Interventions Myo pia Institute: interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci 2019; 60: M106-M31. [ Links ]

29. Wolffsohn JS, Flitcroft DI, Gifford KL, et al. IMI - Myopia Control Reports Overview and Introduction. Invest Oph thalmol Vis Sci 2019; 60: M1-M19. [ Links ]

Received: April 06, 2021; Accepted: July 02, 2021

*Postal address: Rafael Iribarren, Arenales 981, 1061 Buenos Aires, Argentina e-mail: rafairibarren@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License